AI Article Synopsis
- The Clinical Practice Update incorporates findings from the ARRIVE trial and other studies to enhance guidance for managing pregnancies between 39 to 41 weeks gestation without medical reasons for delivery.
- This update revises the American College of Obstetricians and Gynecologists' previous recommendations in Practice Bulletin No. 146 from 2014.
- It replaces earlier clinical guidance related to the ARRIVE trial, which focused on labor versus expectant management for low-risk first-time mothers published in August 2018.
Article Abstract
This Clinical Practice Update integrates data from a large, randomized controlled trial (the ARRIVE trial [A Randomized Trial of Induction Versus Expectant Management]) and subsequent other related studies into existing American College of Obstetricians and Gynecologists' guidance regarding management of pregnant individuals at 39 0/7-41 6/7 weeks of gestation without a medical indication for delivery. This document updates Practice Bulletin No. 146, Management of Late-Term and Postterm Pregnancies (Obstet Gynecol 2014;124:390-396) and replaces the Clinical Guidance for Integration of the Findings of the ARRIVE Trial: Labor Versus Expectant Management in Low-Risk Nulliparous Women Practice Advisory, originally published in August 2018.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/AOG.0000000000005783 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!